Novartis shelves potential blockbuster pelacarsen as landmark study fails
At a glance
- $NVS today+0.38%last $162.55
- 52-week range4.6% below high$123.24 – $170.46
- Coverage3 this week9 in 30 days · about its usual pace
- Sector scannerCalmHealth Care
What it means
- What to watch: Policy moves the whole healthcare aisle; trial data moves one company. Knowing which kind of story this is helps.
- How the stock is trading: $NVS +0.38% in the latest session.
- Timing: It landed over the weekend, while the market was off the clock: the change beside it is Friday's, and Monday is the first session that could react. Market holidays are not detected.
Where the stock stands
$NVS last traded at $162.55, +0.38% on the session. That puts it 4.6% shy of its 52-week high of $170.46 and 32% clear of its low of $123.24 — in the upper part of the range. Over the year it has ranged 38% from low to high: a moderate band — it moves, but it rarely makes a scene. These are latest-session quotes, not live prices — the live tape is on the $NVS page.
How much coverage it is getting
In the last 30 days Wook has filed 9 stories about $NVS — 3 of them this week. At its 30-day pace you would expect about 2 a week, so this week is somewhat busier than usual. Across those stories 1 read bullish, 6 neutral and 2 bearish — mostly headline writers keeping a straight face. This one reads neutral, so it sits squarely with the crowd. 3 came from Investing.com and the rest from other outlets — broad coverage, not one desk talking to itself. 12 related stories from the same name or desk are listed beside this one.
The bigger picture
Healthcare stories turn on approvals, trial data and pricing: one FDA decision or trial readout can swing a single drugmaker hard, while drug-pricing policy moves the whole group at once. Wook's supply-chain scanner has Health Care reading calm today: no unusual stress in the filings and disclosures it watches.
What to watch next
For the receipts, the $NVS page has the full chart, the filings and the valuation model these figures come from. Want the facts without the spin? Read how two or three outlets frame the same story — where they agree is the news, where they differ is the angle. And Wook AI, up top, will happily do the math — how far $NVS sits from its high, or how this week's coverage stacks up.
Discussion
No one has weighed in yet. Start the discussion on this story.